L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats.

L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats.
复制标题

DOI:
10.1016/j.freeradbiomed.2009.03.014
复制
发表时间:
2009-06-15
影响因子:
7.4
通讯作者:
Bull, Rebeca
Bull, Rebeca
中科院分区:
医学1区
文献类型:
--
作者:
Jain, Sushil K.;Velusamy, Thirunavukkarasu;Croad, Jennifer L.;Rains, Justin L.;Bull, Rebeca

文献摘要

参考文献

被引文献

相似文献

This study examined the hypothesis that L-cysteine supplementation can lower insulin resistance, glycemia, oxidative stress and markers of vascular inflammation in type 2 diabetes using zucker diabetic rats (ZDF) rats as a model. Starting at age of 6 wks, ZDF rats were supplemented orally (daily gavage, 8 wks) with saline-placebo (D) or L-cysteine (LC, 1mg/KgBW) and fed a high calorie diet. 6 weeks age rats without any supplementation were considered baseline (BL) rats. D rats showed elevated fasting blood glucose, GHb, CRP, and MCP-1 when compared with BL in which there was no onset of diabetes. LC supplementation significantly lowered blood levels of glucose (18%, p=0.05), GHb (8%, p=0.02), CRP (23%, p=0.02), MCP-1 (32%, p=0.01) and insulin resistance (25%) compared with levels seen in saline-supplemented D. There was a decrease in plasma protein oxidation levels (p<0.01); however, GSH levels were similar in LC and D groups. While LC did not change blood hematocrit or levels of transaminases, it did lower alkaline phosphatase (29%, p=0.01) levels in comparison to D. Western blotting analyses of liver showed increased activation of NFkB and Akt (50% pNFkB and 20% pAkt) in D compared with BL. LC supplementation inhibited these effects (17% pAkt, 18% pNFkB). This is the first report showing L-cysteine supplementation can lower glycemia and markers of vascular inflammation in diabetes apparently mediated by preventing NFkB activation in a diabetic animal model.
DOI: 10.1016/0891-5849(96)02051-5
发表时间: 1996-01-01
影响因子: 7.4
作者:
Lenzen, S;Drinkgern, J;Tiedge, M
通讯作者: Tiedge, M
DOI: 10.1016/j.ejphar.2008.05.006
发表时间: 2008-07-28
影响因子: 5
作者:
Ismael, Mahmoud Ali;Talbot, Sebastien;Couture, Rejean
通讯作者: Couture, Rejean
DOI: 10.1016/j.metabol.2008.04.010
发表时间: 2008-09-01
影响因子: 9.8
作者:
Godsland, Ian F.;Johnston, Desmond G.
通讯作者: Johnston, Desmond G.
DOI: 10.1097/mpa.0b013e31811f44fd
发表时间: 2007-11-01
期刊: PANCREAS
影响因子: 2.9
作者:
Hsiao, Jeng-Yueh;Wang, Chiao-Ling;Shin, Shyi-Jang
通讯作者: Shin, Shyi-Jang
DOI: 10.1093/ajcn/88.3.738
发表时间: 2008-09-01
影响因子: 7.1
作者:
Elshorbagy, Amany K.;Nurk, Eha;Refsum, Helga
通讯作者: Refsum, Helga